Caspase-13 Inhibitor LEED-FMK

Details for Product No. ABIN412051, Supplier: Log in to see
Application
Functional Studies (Func), Cell Culture (CC), Blocking Reagent (BR), Inhibition Assay (InhA)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Purpose A caspase-13 inhibitor
Sequence Z-Leu-Glu(OMe)-Glu(OMe)-Asp(OMe)-FMK
Characteristics PubChem CID: 44135223
A synthetic peptide inhibitor that inhibits caspase-13 and related caspase activity. FMK inhibitors are irreversible and non-toxic, and can be used in both in vivo and in vitro studies. The inhibitor is designed as a methyl ester to facilitate cell permeability. (CAUTION: If the intended use is on purified or recombinant enzymes, esterase should be added to generate free carboxyl groups).
Purity > 95 % by HPLC
Chemical Name Z-LEED-FMK, Z-LEED-fluoromethylketone, Caspase-13 Inhibitor (fluoromethylketone)
Formula C₃₂H₄₅FN₄O₁₂
Permeability Cell-permeable
Solubility In DMSO (10 mM)
Molecular Weight 696.7 g/mol
Application Notes We recommend using 1000-5000X dilutions for inhibiting caspase-13 and related caspase activity (e.g., Add 1 µL to 1-5 mL of culture medium). The optimal doses may vary among different cells and culture conditions. The inhibitor is designed as a methyl ester to facilitate cell permeability.
Restrictions For Research Use only
Format Liquid
Concentration 10 mM
Handling Advice Protect from light and moisture
Storage -20 °C
Expiry Date 12 months
Product cited in: Bian, Sun, Silver, Ho, Marchionni, Caggiano, Stone, Amende, Hampton, Morgan, Yan: "Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins." in: American journal of physiology. Heart and circulatory physiology, Vol. 297, Issue 6, pp. H1974-83, 2009 (PubMed).